Tissue Repair Ltd Announces Major Milestones
Company Announcements

Tissue Repair Ltd Announces Major Milestones

Tissue Repair Ltd (AU:TRP) has released an update.

Tissue Repair Ltd has achieved a significant milestone by securing Listed Medicine status with the TGA for Glucoprime®, with a PR launch planned for Q1 2025, allowing the company to make healing claims and expand marketing. The company is also set to file a device application in the US for Glucoprime® as a skin substitute, aiming to penetrate the market before drug approval. Additionally, Tissue Repair Ltd reported a 100% sales growth for TR Pro+™ over the previous quarter, with strong product effectiveness feedback and sales reaching approximately $26k per month across numerous clinics.

For further insights into AU:TRP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App